Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer von Narayan, Gopeshwar, Scotto, Luigi, Neelakantan, Vijayalakshmi, Kottoor, Sherine H., Wong, Ada Ho Yan, Loke, Shee-Loong, Mansukhani, Mahesh, Pothuri, Bhavana, Wright, Jason D., Kaufmann, Andreas M., Schneider, Achim, Arias-Pulido, Hugo, Tao, Qian, Murty, Vundavalli V.

Volltext

Endogenous cortisol and TGF-beta in human aqueous humor contribute to ocular immune privilege by regulating dendritic cell function von Denniston, Alastair K, Kottoor, Sherine H, Khan, Imran, Oswal, Kadambari, Williams, Geraint P, Abbott, Joseph, Wallace, Graham R, Salmon, Mike, Rauz, Saaeha, Murray, Philip I, Curnow, S John

Volltext

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab von Lin, Simeng, Kennedy, Nicholas A, Saifuddin, Aamir, Sandoval, Diana Muñoz, Reynolds, Catherine J, Seoane, Rocio Castro, Kottoor, Sherine H, Pieper, Franziska P, Lin, Kai-Min, Butler, David K, Chanchlani, Neil, Nice, Rachel, Chee, Desmond, Bewshea, Claire, Janjua, Malik, McDonald, Timothy J, Sebastian, Shaji, Alexander, James L, Constable, Laura, Lee, James C, Murray, Charles D, Hart, Ailsa L, Irving, Peter M, Jones, Gareth-Rhys, Kok, Klaartje B, Lamb, Christopher A, Lees, Charlie W, Altmann, Daniel M, Boyton, Rosemary J, Goodhand, James R, Powell, Nick, Ahmad, Tariq, CLARITY IBD study

Volltext bestellen

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab von Lin, Simeng, Kennedy, Nicholas A, Saifuddin, Aamir, Sandoval, Diana Muñoz, Reynolds, Catherine J, Seoane, Rocio Castro, Kottoor, Sherine H, Pieper, Franziska P, Lin, Kai-Min, Butler, David K, Chanchlani, Neil, Nice, Rachel, Chee, Desmond, Bewshea, Claire, Janjua, Malik, McDonald, Timothy J, Sebastian, Shaji, Alexander, James L, Constable, Laura, Lee, James C, Murray, Charles D, Hart, Ailsa L, Irving, Peter M, Jones, Gareth-Rhys, Kok, Klaartje B, Lamb, Christopher A, Lees, Charlie W, Altmann, Daniel M, Boyton, Rosemary J, Goodhand, James R, Powell, Nick, Ahmad, Tariq, CLARITY IBD study

Volltext bestellen

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab von Lin, Simeng, Kennedy, Nicholas A, Saifuddin, Aamir, Sandoval, Diana Munoz, Reynolds, Catherine J, Seoane, Rocio Castro, Kottoor, Sherine H, Pieper, Franziska P, Lin, Kai-Min, Butler, David K, Chanchlani, Neil, Nice, Rachel, Chee, Desmond, Bewshea, Claire, Janjua, Malik, McDonald, Timothy J, Sebastian, Shaji, Alexander, James L, Constable, Laura, Lee, James C, Murray, Charles D, Hart, Ailsa L, Irving, Peter M, Jones, Gareth-Rhys, Kok, Klaartje B, Lamb, Christopher A, Lees, Charlie W, Altmann, Daniel M, Boyton, Rosemary J, Goodhand, James R, Powell, Nick, Ahmad, Tariq

Volltext bestellen

Su1817 FAECAL LOSS OF VEDOLIZUMAB IS ASSOCIATED WITH UC SEVERITY, LOWER SERUM VEDOLIZUMAB LEVELS AND RATES OF CLINICAL RESPONSE - RESULTS FROM THE FAVOUR STUDY von Samaan, Mark A., Cunningham, Georgina, Lim, Samuel H., Dawson, Patrick, Kottoor, Sherine Hermangild, Bheekhun, Zareen, Odukwe, Sopuluchukwu, Balachandran, Senthuran, Lee, Emma, Anderson, Simon H., Mawdsley, Joel, Ray, Shuvra, Powell, Nick, Dart, Robin J., Rawstron, Krystal, Arkir, Zehra, Irving, Peter M.

Volltext